Viewing data from:

METHYLPREDNISOLONE SODIUM SUCCINATE

ANDA

METHYLPREDNISOLONE SODIUM SUCCINATE | A040583 | FRESENIUS KABI USA LLC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: SOLU-MEDROL(TE code: AP)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$4.04

per ea

Lowest NADAC/Unit

$4.04

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
63323025803METHYLPREDNISOLONE SS 125 MG	$4.04	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$54.67

Highest Price

$63.22

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
63323-0255-03METHYLPREDNISOLONE NA SUCCINATE 40MG/VIL INJ	$54.67	FSS	Fresenius Kabi, LLC	05/14/2030
63323-0258-03METHYLPREDNISOLONE NA SUCCINATE 125MG/VIL INJ	$63.22	FSS	Fresenius Kabi, LLC	05/14/2030

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

LUPIN LTDMETHYLPREDNISOLONE SODIUM SUCCINATE

DMF 303752016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 2, 2004	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 40MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jul 30, 2004

No patent or exclusivity listings for this strength.

#002 — EQ 125MG BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Jul 30, 2004